doi: 10.1021/jm00187a009.
5-Iminodaunorubicin. Reduced cardiotoxic properties in an antitumor anthracycline
- PMID: 423181
- DOI: 10.1021/jm00187a009
Item in Clipboard
5-Iminodaunorubicin. Reduced cardiotoxic properties in an antitumor anthracycline
J Med Chem.
1979 Jan.
Abstract
Treatment of daunorubicin with methanolic ammonia affords 5-iminodaunorubicin, the first quinone-modified analogue of either daunorubicin or adriamycin. This product retains antileukemic activity in mice, is less cardiotoxic by electrocardiographic measurements in rats, and is nonmutagenic in Salmonella typhimurium (Ames test).
Similar articles
-
Antitumor anthracycline antibiotics. Structure-activity and structure-cardiotoxicity relationships of rubidazone analogues.J Med Chem. 1978 Aug;21(8):732-7. doi: 10.1021/jm00206a003. J Med Chem. 1978. PMID: 690999
-
Synthesis of daunorubicin analogues with novel 9-acyl substituents.J Med Chem. 1979 Jan;22(1):40-4. doi: 10.1021/jm00187a010. J Med Chem. 1979. PMID: 423182
-
Diminished superoxide anion generation by reduced 5-iminodaunorubicin relative to daunorubicin and the relationship to cardiotoxicity of the anthracycline antitumor agents.Biochem Pharmacol. 1979 Sep 1;28(17):2563-8. doi: 10.1016/0006-2952(79)90027-3. Biochem Pharmacol. 1979. PMID: 229856 No abstract available.
-
Anthracycline mechanisms in analogue selection.Drugs Exp Clin Res. 1985;11(1):1-8. Drugs Exp Clin Res. 1985. PMID: 3915272 Review.
-
A modified screening system to select new cytostatic drugs.Behring Inst Mitt. 1984 May;(74):301-28. Behring Inst Mitt. 1984. PMID: 6383326 Review. No abstract available.
Cited by
-
Comparative effects of doxorubicin and 4'-epi-doxorubicin on nucleic acid metabolism and cytotoxicity in a human tumor cell line.Cancer Chemother Pharmacol. 1990;27(1):47-51. doi: 10.1007/BF00689275. Cancer Chemother Pharmacol. 1990. PMID: 1700932
-
Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.Pharm Weekbl Sci. 1986 Apr 25;8(2):109-33. doi: 10.1007/BF02086146. Pharm Weekbl Sci. 1986. PMID: 3520474 Review.
-
Prevention of adriamycin toxicity.Cancer Chemother Pharmacol. 1983;11(2):91-3. doi: 10.1007/BF00254252. Cancer Chemother Pharmacol. 1983. PMID: 6627601
-
The pharmacokinetics and toxicity of the anthrapyrazole anti-cancer drug CI-941 in the mouse: a guide for rational dose escalation in patients.Cancer Chemother Pharmacol. 1989;23(1):8-14. doi: 10.1007/BF00258450. Cancer Chemother Pharmacol. 1989. PMID: 2909292
-
Effects of 5-iminodaunorubicin on nucleoli of rats.Cancer Chemother Pharmacol. 1980;4(4):263-6. doi: 10.1007/BF00255271. Cancer Chemother Pharmacol. 1980. PMID: 7438328